Kerri Fitzgerald

DocwireNews

A report published in Morbidity and Mortality Weekly Report found that oropharyngeal squamous cell carcinoma (SCC) is now the most common HPV-associated cancer in the United States, taking the place of cervical cancer, which was the most common. 
Researchers at the analyzed data from population-based cancer registries that participate in the Center for Disease Control and Prevention’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results program from 1999 to 2015.  
A total of 30,115 new cases of HPV-associated cancers were reported in 1999 and 43,371 were reported in 2015. In 1999, cervical carcinoma (13,125 cases) was the most common HPV-associated cancer, with 3,750 more cases than oropharyngeal SCC. Researchers observed that cervical carcinoma incidence rates decreased 1.6% per year during that time period, while oropharyngeal SCC incidence rates increased 2.7% per year among men and 0.8% per year among women. In 2015, there were 11,788 reported cases of cervical carcinoma and 18,917 cases of oropharyngeal SCC, including 15,479 (82%) among men and 3,438 (18%) among women. 
“The decline in cervical cancer from 1999 to 2015 represents a continued trend since the 1950s as a result of cancer screening,” the researchers noted. 
<a href="https://proddocwire.wpengine.com/docwire-pick/hem-onc-picks/hpv-esophageal-cancer-survival/">A study assessed the survival impact of HPV-related esophageal cancer.</a> 
<a href="https://proddocwire.wpengine.com/hematology-oncology/hpv-test-identifies-cervical-precancer-earlier-than-pap/">An HPV test identifies cervical precancer earlier than the Pap test.</a> 
Source: <a href="https://www.cdc.gov/mmwr/volumes/67/wr/mm6733a2.htm?s_cid=mm6733a2_w">Morbidity and Mortality Weekly Report </a>

Zachary Bessette

UNION: Longitudinal ctDNA for Predicting Response to Short-Course Rectal Cancer Neoadjuvant RT

ASCO 2024: Focus on GI Oncology

Andrew Moreno

Large Population Study Bolsters Aspirin as VTE Prophylaxis of Choice in Joint Arthroplasty

Emily Menendez

Camrelizumab Plus Rivoceranib Boosts Survival Rates Over Sorafenib in uHCC

Unresectable HCC

Latest News

CDC Says Oropharyngeal Cancer Most Common HPV-Related Cancer

Head and Neck Cancer

A report published in Morbidity and Mortality Weekly Report found that oropharyngeal squamous cell carcinoma (SCC) is now the most common HPV-associated cancer in the ...

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Diabetes

Neurology

Rheumatology

Gastroenterology

Pulmonology

Ophthalmology

Infectious Diseases

— HIV

Health and Wellness

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Fellow on Call

Healthcare Unfiltered

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Career Center

Expert Interviews

Subscribe